Back
ProShares Ultra Nasdaq Biotechnology Vs. ProShares Ultra Real Estate Industry Stock Comparison
Buy
66
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
54.60
Seasonality Move:
12.47%
Buy
68
URE
ProShares Ultra Real Estate
Last Price:
55.28
Seasonality Move:
0.85%
Buy
66
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Buy
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $55.42. The Score for BIB is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- BIB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
ProShares Ultra Real Estate (URE)
is a Buy
Is ProShares Ultra Real Estate a Buy, Sell or Hold?
- The current ProShares Ultra Real Estate [URE] share price is $55.77. The Score for URE is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- URE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $55.42
The current trend is moderately bullish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
URE Stock Price Chart
What is ProShares Ultra Real Estate's stock price today?
-
The ProShares Ultra Real Estate share price today is $55.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URE is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 59.19 | Buy |
| Chaikin Money Flow: | 10621 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.39 - 54.45) | Buy |
| Bollinger Bands (100): | (52.81 - 59.25) | Sell |
URE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 57.31 | Buy |
| Chaikin Money Flow: | 3338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.48 - 55.78) | Buy |
| Bollinger Bands (100): | (54.37 - 61.81) | Sell |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.23 | Buy |
| 20-day SMA: | 51.48 | Buy |
| 50-day SMA: | 54.45 | Buy |
| 200-day SMA: | 52.04 | Buy |
| 8-day EMA: | 54.24 | Buy |
| 20-day EMA: | 53.12 | Buy |
| 50-day EMA: | 53.82 | Buy |
| 200-day EMA: | 53.6 | Buy |
URE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.97 | Buy |
| 20-day SMA: | 52.07 | Buy |
| 50-day SMA: | 56.51 | Sell |
| 200-day SMA: | 54.79 | Buy |
| 8-day EMA: | 53.51 | Buy |
| 20-day EMA: | 53.42 | Buy |
| 50-day EMA: | 55.13 | Buy |
| 200-day EMA: | 56.4 | Sell |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Real Estate Earnings Growth & URE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Real Estate Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||